3-Amino-5-(1-azepanyl)-N-carbamimidoyl-6-chloro-2-pyrazinecarboxamide(CAS: 1428-95-1)

3-Amino-5-(1-azepanyl)-N-carbamimidoyl-6-chloro-2-pyrazinecarboxamide (CAS: 1428-95-1) must comply with various regulatory guidelines, including GHS classification for hazardous substances, REACH regulations in the European Union, and FDA/EPA requirements for chemical substances used in pharmaceuticals and environmental releases. Proper labeling and documentation are essential to ensure compliance.

Alternatives to 3-Amino-5-(1-azepanyl)-N-carbamimidoyl-6-chloro-2-pyrazinecarboxamide (CAS: 1428-95-1) include related compounds such as analogs and isomers, which can serve similar functions in synthesis. Common alternative reagents include other biaryl compounds with varying substituents, depending on the specific application and desired properties.

The market and research trends for 3-Amino-5-(1-azepanyl)-N-carbamimidoyl-6-chloro-2-pyrazinecarboxamide (CAS: 1428-95-1) are driven by its potential applications in pharmaceuticals, specifically as a potential intermediate in the synthesis of drugs. Emerging research focuses on its biological activity and its use in developing novel therapeutic agents. Market trends indicate increasing interest in its use in advanced medicinal chemistry.

Waste containing 3-Amino-5-(1-azepanyl)-N-carbamimidoyl-6-chloro-2-pyrazinecarboxamide (CAS: 1428-95-1) should be collected and disposed of according to hazardous waste regulations. Waste liquids should be collected in suitable containers and incinerated or disposed of by professional waste disposal services. Environmental protection precautions include proper containment to prevent exposure and ecological harm.